98 related articles for article (PubMed ID: 31805808)
1. Development and validation of a prediction model for identifying men with intermediate- or high-risk prostate cancer for whom bone imaging is unnecessary: a nation-wide population-based study.
Godtman RA; Månsson M; Bratt O; Robinsson D; Johansson E; Stattin P; Kjölhede H
Scand J Urol; 2019 Dec; 53(6):378-384. PubMed ID: 31805808
[No Abstract] [Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Establishing the pathways and indications for performing isotope bone scans in newly diagnosed intermediate-risk localised prostate cancer - results from a large contemporaneous cohort.
KandaSwamy GV; Bennett A; Narahari K; Hughes O; Rees J; Kynaston H
BJU Int; 2017 Nov; 120(5B):E59-E63. PubMed ID: 28317247
[TBL] [Abstract][Full Text] [Related]
4. Developing a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zone.
Niu XK; Li J; Das SK; Xiong Y; Yang CB; Peng T
BMC Med Imaging; 2017 Feb; 17(1):11. PubMed ID: 28143433
[TBL] [Abstract][Full Text] [Related]
5. Are prostate biopsies necessary for all patients 75years and older?
Chen Y; Fan Y; Yang Y; Jin J; Zhou L; He Z; Zhao Z; He Q; Wang X; Yu W; Wu S
J Geriatr Oncol; 2018 Mar; 9(2):124-129. PubMed ID: 28939384
[TBL] [Abstract][Full Text] [Related]
6. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.
Briganti A; Passoni N; Ferrari M; Capitanio U; Suardi N; Gallina A; Da Pozzo LF; Picchio M; Di Girolamo V; Salonia A; Gianolli L; Messa C; Rigatti P; Montorsi F
Eur Urol; 2010 Apr; 57(4):551-8. PubMed ID: 20034730
[TBL] [Abstract][Full Text] [Related]
7. Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study.
Thomsen FB; Westerberg M; Garmo H; Robinson D; Holmberg L; Ulmert HD; Stattin P
PLoS One; 2020; 15(1):e0228447. PubMed ID: 31995611
[TBL] [Abstract][Full Text] [Related]
8. [The building and validation of a model to predict the bone metastases of patients with newly diagnosed prostate cancer].
Zhou JQ; Zhu Y; Yao XD; Zhang SL; Dai B; Zhang HL; Ye DW
Zhonghua Wai Ke Za Zhi; 2012 Nov; 50(11):999-1002. PubMed ID: 23302484
[TBL] [Abstract][Full Text] [Related]
9. Toward an MRI-based nomogram for the prediction of transperineal prostate biopsy outcome: A physician and patient decision tool.
Lee SM; Liyanage SH; Wulaningsih W; Wolfe K; Carr T; Younis C; Van Hemelrijck M; Popert R; Acher P
Urol Oncol; 2017 Nov; 35(11):664.e11-664.e18. PubMed ID: 28801025
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen, Gleason sum and clinical T stage for predicting the need for radionuclide bone scan for prostate cancer patients in Japan.
Ishizuka O; Tanabe T; Nakayama T; Kawakami M; Kinebuchi Y; Nishizawa O
Int J Urol; 2005 Aug; 12(8):728-32. PubMed ID: 16174046
[TBL] [Abstract][Full Text] [Related]
11. Development of a nomogram predicting metastatic disease and the assessment of NCCN, AUA and EAU guideline recommendations for bone imaging in prostate cancer patients.
Ma MW; Gao XS; Lyu F; Gu XB; Yin H; Li HZ; Li XY; Qi X; Bai Y; Chen JY
World J Urol; 2021 Jun; 39(6):1815-1823. PubMed ID: 32691147
[TBL] [Abstract][Full Text] [Related]
12. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of a novel risk stratification tool.
De Nunzio C; Leonardo C; Franco G; Esperto F; Brassetti A; Simonelli G; Dente D; De Dominicis C; Tubaro A
World J Urol; 2013 Apr; 31(2):365-9. PubMed ID: 22576696
[TBL] [Abstract][Full Text] [Related]
13. Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer.
Miyoshi Y; Noguchi K; Yanagisawa M; Taguri M; Morita S; Ikeda I; Fujinami K; Miura T; Kobayashi K; Uemura H
BMC Cancer; 2015 May; 15():338. PubMed ID: 25929438
[TBL] [Abstract][Full Text] [Related]
14. Survival analysis and development of a prognostic nomogram for bone-metastatic prostate cancer patients: A single-center experience in Indonesia.
Afriansyah A; Hamid ARA; Mochtar CA; Umbas R
Int J Urol; 2019 Jan; 26(1):83-89. PubMed ID: 30269369
[TBL] [Abstract][Full Text] [Related]
15. A new nomogram for the prediction of bone metastasis in patients with prostate cancer.
Bai G; Cai Z; Zhai X; Xiong J; Zhang F; Li H
J Int Med Res; 2021 Nov; 49(11):3000605211058364. PubMed ID: 34786998
[TBL] [Abstract][Full Text] [Related]
16. Development and internal validation of a side-specific, multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer.
Martini A; Gupta A; Lewis SC; Cumarasamy S; Haines KG; Briganti A; Montorsi F; Tewari AK
BJU Int; 2018 Dec; 122(6):1025-1033. PubMed ID: 29676063
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of prognostic nomograms for patients with metastatic prostate cancer.
Jiang WD; Yuan PC
Int Urol Nephrol; 2019 Oct; 51(10):1743-1753. PubMed ID: 31289983
[TBL] [Abstract][Full Text] [Related]
18. Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital.
O'Sullivan JM; Norman AR; Cook GJ; Fisher C; Dearnaley DP
BJU Int; 2003 Nov; 92(7):685-9. PubMed ID: 14616446
[TBL] [Abstract][Full Text] [Related]
19. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
[TBL] [Abstract][Full Text] [Related]
20. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.
Nakanishi H; Wang X; Ochiai A; Trpkov K; Yilmaz A; Donnelly JB; Davis JW; Troncoso P; Babaian RJ
Cancer; 2007 Dec; 110(11):2441-7. PubMed ID: 17932909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
